Chongqing Peg-bio Biopharm Co., Ltd.

This study tests a drug called PJ009 in people with short bowel syndrome who rely on IV nutrition. The goal is to see if PJ009 can safely reduce the amount of IV nutrition they need. About 72 participants aged 14 and older will receive daily injections of PJ009 or a placebo for 2…

This early study tests a new drug called PN20 in 12 adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Participants receive one injection and are monitored for safety and platelet count changes. The go…

This study tests a single shot of PN20, a lab-made protein, to safely raise platelet counts in adults with chronic liver disease who have low platelets and need a planned procedure. About 54 participants will get either PN20 or a placebo before their procedure. The goal is to see…